Metraipolis › archive › dc_635f997bafcb

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41739470
DOI
10.1001/jamanetworkopen.2026.0146
License (as archived)
solo-consultazione
Archived
2026-11-06T07:30:28.380Z
SHA-256 of the archived text
4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6
Stable URL of this page
https://metraipolis.com/documento/dc_635f997bafcb

How to cite

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470 — Europe PMC (en), https://europepmc.org/article/MED/41739470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_635f997bafcb (Metraipolis archive dc_635f997bafcb, sha256 4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6)
BibTeX
@misc{dc635f997bafcb,
  title = {SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41739470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_635f997bafcb; sha256 4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41739470. Agents can read the archived copy with the MCP tool read_document.